New drug tested to help liver recovery after cancer surgery
Disease control
Recruiting now
This study is testing whether a new drug called HRX215 is safe for people who have had surgery to remove liver tumors from colorectal cancer. Researchers will give the drug or a placebo to 25 adults for 28 days after their surgery and monitor them closely. The main goal is to che…
Phase: PHASE1, PHASE2 • Sponsor: HepaRegeniX GmbH • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC